![]() 1,156,016,075 visitors served. |
|
![]() Dictionary/ thesaurus | ![]() Medical dictionary | ![]() Legal dictionary | ![]() Financial dictionary | ![]() Acronyms | ![]() Idioms | ![]() Encyclopedia | ![]() Wikipedia encyclopedia | ? |
MA(IMP) |
0.03 sec. |
How to thank TFD for its existence? Tell a friend about us, add a link to this page, add the site to iGoogle, or visit webmaster's page for free fun content. |
|
? References in periodicals archive |
|---|
The European Marketing Authorisation Application (MAA) for Sancuso was lodged in July 2007 and the Company expects EU approval in H2 2008, with European country launches commencing in 2009. Note that this is 23 years after marketing authorisation (which took on average 10-13 years in this study) - so 33 to 36 years after the priority date of the original composition of matter patent. has submitted a Marketing Authorisation Application (MAA) to the European Medicines Evaluation Agency (EMEA) for adefovir dipivoxil 10 mg. |
| Free Tools: |
For surfers:
Browser extension |
Word of the Day |
Help
For webmasters: Free content | Linking | Lookup box | Double-click lookup | Partner with us |
|
|---|